SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-22-000076
Filing Date
2022-01-18
Accepted
2022-01-14 18:07:45
Documents
58
Period of Report
2021-11-30

Document Format Files

Seq Description Document Type Size
1 cbgl_10q-113021v3.htm   iXBRL 10-Q 803169
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 6609
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 6612
4 EXHIBIT 32.1 ex32x1.htm EX-32.1 4892
  Complete submission text file 0001079973-22-000076.txt   4827039

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cbgl-20211130.xsd EX-101.SCH 44543
6 XBRL CALCULATION FILE cbgl-20211130_cal.xml EX-101.CAL 51000
7 XBRL DEFINITION FILE cbgl-20211130_def.xml EX-101.DEF 216056
8 XBRL LABEL FILE cbgl-20211130_lab.xml EX-101.LAB 293102
9 XBRL PRESENTATION FILE cbgl-20211130_pre.xml EX-101.PRE 290531
52 EXTRACTED XBRL INSTANCE DOCUMENT cbgl_10q-113021v3_htm.xml XML 549389
Mailing Address 520 S. GRAND AVENUE SUITE 320 LOS ANGELES CA 90071
Business Address 520 S. GRAND AVENUE SUITE 320 LOS ANGELES CA 90071 (310) 986-4929
CANNABIS GLOBAL, INC. (Filer) CIK: 0001413488 (see all company filings)

IRS No.: 831754057 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-56141 | Film No.: 22532977
SIC: 2836 Biological Products, (No Diagnostic Substances)